PSYD_0302: BIRMINGHAM

<i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>A randomised, double-blind, placebo-controlled trial in participants with a recent-onset schizophrenia-spectrum disorder with continuing positive symptoms.</b><b>Contributors and PIs:</b> John F. W. DeakinNeuroscience and Psychiatry Unit, The University of Manchester, Manchester, UKInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK<b>Key Details &amp; Variables</b><b>Data Type</b>Image data/Feature data<b>Age Range</b>19-34<b>Number of Participants</b>28<b>Diagnostic Criteria</b>SCZ<b>Number of Clinical Subjects</b>18<b>Number of Clinical Subjects (follow-up)</b>10<b>Number of Control Subjects</b>N/A<b>Number of Control Subjects (follow-up)</b>N/A<b>Demographic Information</b>Age, Sex, Ethnicity, Handedness, Education<b>Clinical Measures</b>PANSS, CDSS, EPS, MAH, COO<b>Cognitive Measures</b>N/A<b>Clinical Functioning Measures</b>GAF<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>Name<b>Antipsychotic Dose Recorded</b>Yes<b>CPZ Equivalents Recorded</b>N/A<b>Other Medication Variables Recorded</b>Yes<b>Recreational Drug/ Alcohol Use</b>Yes<i>Note: the above table features key details and variables and is not an exhaustive list.</i>